Chicory fiber study seeks to unlock secrets of gut microbe changes
NCT ID NCT06528041
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks at how a prebiotic fiber from chicory root (inulin) changes gut bacteria in healthy adults aged 18-45. Over 13 weeks, participants take either inulin or a placebo (maltodextrin) and provide stool and blood samples. Researchers track changes in Bifidobacterium and other gut microbes, along with bowel habits, mood, and appetite. The goal is to understand why people's gut bacteria respond differently to the same fiber.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- chicory inulin (a prebiotic fiber supplement)
- What this could lead to
- If successful, this study could reveal how individuals respond differently to prebiotic fiber, helping personalize dietary recommendations for gut health.
- What could go wrong
- This is an early-stage, small study (52 healthy adults) focused on measuring changes, not treating a disease. Results may not apply to people with health conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Purdue University
RECRUITINGWest Lafayette, Indiana, 47907, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test